Summary
Despite severe supply chain disruptions from conflicts in West Asia, India's pharmaceutical exports grew 6.8% in Q1 FY27, according to Pharmexcil. The Pharmexcil chief stated that war-related supply chain shocks are the 'new normal' for Indian pharma, backed by strong international trust.